Kathleen Leary in New York, New York

Home New York New York

Kathleen Leary has Nurse Practitioner as her primary medical specialty. Their primary office is: 1275 York Ave in New York, New York. There is an additional office location, for a total of two, for Kathleen Leary that can be viewed further down.

They're a part of the: Mskcc Surgery Group medical group which has around 271 members. You can call their office at 212-639-2000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2008 (around 16 years of experience). They are listed as doing telehealth appointments.

Kathleen M Leary Office Phone and Directions

Kathleen Leary
Mskcc Surgery Group
1275 York Ave
New York, New York 10065
212-639-2000

Patient Ratings
Please rate your experience with Kathleen Leary below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 212-639-2000

Enter a starting address:

Healthcare Info for Kathleen Leary

Medical School: Sorry, her university is not listed
Graduation Year: 2008
The Primary Medical Specialty for Kathleen Leary is listed as: Nurse Practitioner
Approximate Years of Experience: 16
PAC (PECOS ID)#: 7911194675
NPI #: 1508091273
NPI Created On: 05/23/2009
NPI Last Updated Listed as: 02/28/2014
Primary Taxonomy Code: 363LF0000X
License Number:
F335616-1
Listed Gender: Female

Procedures, Services, Charges

Services and Procedures include:

Established patient office or other outpatient, visit typically 25 minutes

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 836051297

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: POLIVY

Open Associated Drug #1: 50242-105-01